Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Other Long-Term Liabilities : ¥17.3 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Anhui Wanbang Pharmaceutical Technology Co Other Long-Term Liabilities?

Anhui Wanbang Pharmaceutical Technology Co's other long-term liabilities for the quarter that ended in Mar. 2024 was ¥17.3 Mil.

Anhui Wanbang Pharmaceutical Technology Co's quarterly other long-term liabilities increased from Sep. 2023 (¥12.6 Mil) to Dec. 2023 (¥13.6 Mil) and increased from Dec. 2023 (¥13.6 Mil) to Mar. 2024 (¥17.3 Mil).

Anhui Wanbang Pharmaceutical Technology Co's annual other long-term liabilities increased from Dec. 2021 (¥6.5 Mil) to Dec. 2022 (¥7.7 Mil) and increased from Dec. 2022 (¥7.7 Mil) to Dec. 2023 (¥13.6 Mil).

Anhui Wanbang Pharmaceutical Technology Co Other Long-Term Liabilities Historical Data

The historical data trend for Anhui Wanbang Pharmaceutical Technology Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Wanbang Pharmaceutical Technology Co Other Long-Term Liabilities Chart

Anhui Wanbang Pharmaceutical Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Anhui Wanbang Pharmaceutical Technology Co Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial									-	-	-	-	-

Anhui Wanbang Pharmaceutical Technology Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Anhui Wanbang Pharmaceutical Technology Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Anhui Wanbang Pharmaceutical Technology Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Wanbang Pharmaceutical Technology Co Ltd (SZSE:301520) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

southwest corner of the intersection of Mingzhu Avenue and Huolongdi Road, Building 1, Anhui Wanbang Pharmaceutical, High-tech Zone, Anhui, Hefei, CHN, 230000

Website

http://www.ahwbyy.cn

Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of innovative drugs, improved new drugs and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services and data statistics and analysis.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Headlines

No Headlines